☰

Mary Lesperance - Publications

Affiliations: 
1990 University of Waterloo, Waterloo, ON, Canada 
Tree Info Similar researchers PubMed Report error

45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Freeman AT, Lesperance M, Wai ES, Croteau NS, Fiorino L, Geller G, Brooks EG, Poonja Z, Fenton D, Irons S, Ksienski D. Treatment of non-small-cell lung cancer after progression on nivolumab or pembrolizumab. Current Oncology (Toronto, Ont.). 27: 76-82. PMID 32489249 DOI: 10.3747/Co.27.5495  0.319
2020 Ksienski D, Wai ES, Croteau NS, Freeman AT, Chan A, Fiorino L, Poonja Z, Fenton D, Patterson T, Irons S, Lesperance M. Association of age with differences in immune related adverse events and survival of patients with advanced nonsmall cell lung cancer receiving pembrolizumab or nivolumab. Journal of Geriatric Oncology. PMID 31937494 DOI: 10.1016/J.Jgo.2020.01.006  0.323
2019 Ksienski D, Wai ES, Croteau N, Freeman AT, Chan A, Fiorino L, Brooks EG, Poonja Z, Fenton D, Geller G, Irons S, Lesperance M. Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practice. Lung Cancer (Amsterdam, Netherlands). 133: 110-116. PMID 31200816 DOI: 10.1016/J.Lungcan.2019.05.005  0.335
2019 Ksienski D, Wai ES, Croteau N, Freeman A, Fiorino L, Chan A, Geller GS, Poonja Z, Brooks EG, Fenton D, Irons S, Lesperance M. Pembrolizumab (Pem) for advanced non-small cell lung cancer (aNSCLC): Efficacy and safety in everyday clinical practice. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E20506  0.322
2019 Ksienski D, Wai E, Croteau N, Freeman A, Fiorino L, Chan A, Fenton D, Geller G, Brooks E, Poonja Z, Irons S, Lesperance M. MA07.11 Survival Outcomes Based on Gender of Advanced Nonsmall Cell Lung Cancer Patients Treated with Pembrolizumab or Nivolumab in Everyday Clinical Practice Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.555  0.354
2018 Murchison SC, Wiksyk B, Gossman S, Jensen B, Sayers D, Lesperance M, Truong PT, Alexander A. Subventricular Zone Radiation Dose and Outcome for Glioblastoma Treated Between 2006 and 2012. Cureus. 10: e3618. PMID 30697499 DOI: 10.7759/Cureus.3618  0.303
2018 Ksienski D, Wai ES, Croteau N, Fiorino L, Brooks E, Poonja Z, Fenton D, Geller G, Lesperance M. Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis. Clinical Lung Cancer. PMID 30337270 DOI: 10.1016/J.Cllc.2018.09.005  0.314
2018 Tyler S, Truong PT, Lesperance M, Nichol A, Baliski C, Warburton R, Tyldesley S. Close Margins Less Than 2 mm Are Not Associated With Higher Risks of 10-Year Local Recurrence and Breast Cancer Mortality Compared With Negative Margins in Women Treated With Breast-Conserving Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 29678525 DOI: 10.1016/J.Ijrobp.2018.03.005  0.391
2018 Ksienski D, Wai E, Croteau N, Lesperance M. Safety and clinical efficacy of programmed cell death 1 antibodies (PD-1 Ab) in patients with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 36: 260-260. DOI: 10.1200/Jco.2018.36.30_Suppl.260  0.336
2018 Ksienski D, Wai E, Lesperance M, Croteau N, Fiorino L, Poonja Z, Fenton D, Geller G, Brooks E, Glick D. P1.01-51 Real world Experience of Pembrolizumab in Patients with Metastatic Nonsmall Cell Lung Cancer (mNSCLC) Journal of Thoracic Oncology. 13. DOI: 10.1016/J.Jtho.2018.08.606  0.317
2018 Glick D, Wai E, Lesperance M, Croteau N, Brooks E, Fenton D, Fiorino L, Geller G, Poonja Z, Ksienski D. P1.01-24 Clinical Efficacy of Immunotherapy in Metastatic Non-Small Cell Lung Cancer Patients Treated with Prior Radiotherapy Journal of Thoracic Oncology. 13. DOI: 10.1016/J.Jtho.2018.08.580  0.342
2017 Wai ES, Lesperance M, Lu L, Alexander CS, Truong PT. Effect of Referral Patterns and Treatment Type on Oncologic Outcomes for Women with Ductal Carcinoma In Situ. Cureus. 9: e1128. PMID 28465875 DOI: 10.7759/Cureus.1128  0.33
2017 Tyler S, Truong P, Lesperance M, Nichol A, Baliski C, Warburton R, Tyldesley S. Abstract P1-11-01: The effect of close and positive surgical margins on 10-year local recurrence and survival outcomes in women treated with breast conserving surgery plus adjuvant radiotherapy Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P1-11-01  0.344
2017 Tyler SA, Truong P, Lesperance M, Nichol A, Baliski C, Warburton R, Tyldesley SK. Poster ViewingEffect of Margin Status on 10-Year Local Recurrence and Survival Outcomes in a Large Population-Based Analysis of Women Treated With Breast-Conserving Therapy International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.713  0.351
2017 Tyler SA, Truong P, Lesperance M, Nichol A, Baliski C, Warburton R, Tyldesley S. (S002) Population-Based Analysis of the Effect of Margin Status on 10-Year Local Recurrence and Breast Cancer-Specific Survival in Women Treated With Breast-Conserving Therapy International Journal of Radiation Oncology Biology Physics. 98. DOI: 10.1016/J.Ijrobp.2017.02.038  0.376
2014 Smith SL, Truong PT, Lu L, Lesperance M, Olivotto IA. Identification of patients at very low risk of local recurrence after breast-conserving surgery. International Journal of Radiation Oncology, Biology, Physics. 89: 556-62. PMID 24929165 DOI: 10.1016/J.Ijrobp.2014.03.016  0.364
2014 Canavan J, Truong PT, Smith SL, Lu L, Lesperance M, Olivotto IA. Local recurrence in women with stage I breast cancer: declining rates over time in a large, population-based cohort. International Journal of Radiation Oncology, Biology, Physics. 88: 80-6. PMID 24331653 DOI: 10.1016/J.Ijrobp.2013.10.001  0.372
2012 Berrang TS, Lesperance M, Truong PT, Walter C, Hayashi AH, Olivotto IA. Which prediction models best identify additional axillary disease after a positive sentinel node biopsy for breast cancer? Breast Cancer Research and Treatment. 133: 695-702. PMID 22367621 DOI: 10.1007/S10549-012-1991-Y  0.314
2012 Nguyen DH, Truong PT, Alexander C, Walter CV, Hayashi E, Christie J, Lesperance M. Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis? International Journal of Radiation Oncology, Biology, Physics. 84: 39-45. PMID 22330986 DOI: 10.1200/Jco.2011.29.27_Suppl.89  0.376
2012 Karam I, Lesperance M, Tyldesley S, Speers C, Truong P. Treatment Patterns and Locoregional Recurrence Outcomes in Patients with pN0(i+) Breast Cancer International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.098  0.375
2011 Nichol AM, Yerushalmi R, Tyldesley S, Lesperance M, Bajdik CD, Speers C, Gelmon KA, Olivotto IA. A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4763-8. PMID 22105824 DOI: 10.1200/Jco.2011.35.0165  0.394
2011 Panet-Raymond V, Truong PT, Alexander C, Lesperance M, McDonald RE, Watson PH. Clinicopathologic factors of the recurrent tumor predict outcome in patients with ipsilateral breast tumor recurrence. Cancer. 117: 2035-43. PMID 21523714 DOI: 10.1002/Cncr.25767  0.314
2011 Lupe K, Truong PT, Alexander C, Lesperance M, Speers C, Tyldesley S. Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 81: e561-8. PMID 21514069 DOI: 10.1016/J.Ijrobp.2011.02.021  0.353
2010 Wai ES, Lesperance M, Speers CH, Truong PT, Jones S, Tyldesley S, Olivotto IA. Increased use of regional radiotherapy is associated with improved outcome in a population-based cohort of women with breast cancer with 1-3 positive nodes. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 97: 301-6. PMID 20826030 DOI: 10.1016/J.Radonc.2010.08.008  0.383
2010 Downing GM, Lesperance M, Lau F, Yang J. Survival implications of sudden functional decline as a sentinel event using the palliative performance scale. Journal of Palliative Medicine. 13: 549-57. PMID 20377498 DOI: 10.1089/Jpm.2009.0299  0.314
2010 Truong PT, Lesperance M, Li KH, MacFarlane R, Speers CH, Chia S. Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series. Annals of Surgical Oncology. 17: 2138-46. PMID 20151215 DOI: 10.1245/S10434-010-0954-Y  0.362
2010 Sanghani M, Truong PT, Raad RA, Niemierko A, Lesperance M, Olivotto IA, Wazer DE, Taghian AG. Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 718-22. PMID 20048188 DOI: 10.1200/Jco.2009.22.6662  0.354
2010 Nichol A, Yerushalmi R, Tyldesley S, Lesperance M, Bajdik C, Speers C, Gelmon K, Olivotto I. Abstract P4-09-17: Case-Matching Study Comparing Outcome of Unilateral and Synchronous Bilateral Breast Cancer Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P4-09-17  0.354
2010 Panet-Raymond V, Truong PT, Alexander C, Lesperance M, McDonald RE, Ross LA, Ryhorchuk A, Watson PH. Pathological Factors of the Recurrent Tumor Predict Outcome in Patients with Ipsilateral Breast Tumor Recurrences International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.259  0.307
2009 Lau F, Maida V, Downing M, Lesperance M, Karlson N, Kuziemsky C. Use of the Palliative Performance Scale (PPS) for end-of-life prognostication in a palliative medicine consultation service. Journal of Pain and Symptom Management. 37: 965-72. PMID 19232892 DOI: 10.1016/J.Jpainsymman.2008.08.003  0.343
2009 Lau F, Downing M, Lesperance M, Karlson N, Kuziemsky C, Yang J. Using the Palliative Performance Scale to provide meaningful survival estimates. Journal of Pain and Symptom Management. 38: 134-44. PMID 19171459 DOI: 10.1016/J.Jpainsymman.2008.05.017  0.324
2008 Germain F, Wai ES, Berthelet E, Truong PT, Lesperance M. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy. American Journal of Clinical Oncology. 31: 561-6. PMID 19060588 DOI: 10.1097/Coc.0B013E318172D5F9  0.318
2008 Truong PT, Lesperance M, Sanghani M, Jones S, Tighouart H, Wazer D, Olivotto IA. Independent Validation of IBTR! A Computer-based Tool to Predict Ipsilateral Breast Recurrence in Women with Invasive Breast Cancer Treated with Breast Conserving Surgery International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.975  0.354
2007 Lerch L, Donald JC, Olivotto IA, Lesperance M, van der Westhuizen N, Rusnak C, Biberdorf D, Ross A, Hayashi A. Measuring surgeon performance of sentinel lymph node biopsy in breast cancer treatment by cumulative sum analysis. American Journal of Surgery. 193: 556-9; discussion 56. PMID 17434354 DOI: 10.1016/J.Amjsurg.2007.01.012  0.339
2007 Truong PT, Li K, Lesperance M, Chia S, Macfarlane R, Speers CH, Olivotto A. Micrometastatic Node-positive Breast Cancer: An Analysis of Outcomes in Comparison to Node-negative and Macrometastatic Node-positive Disease Clinical Oncology. 19. DOI: 10.1016/J.Clon.2007.01.426  0.302
2006 Lau F, Downing GM, Lesperance M, Shaw J, Kuziemsky C. Use of Palliative Performance Scale in end-of-life prognostication. Journal of Palliative Medicine. 9: 1066-75. PMID 17040144 DOI: 10.1089/Jpm.2006.9.1066  0.323
2006 Truong PT, Bernstein V, Lesperance M, Speers CH, Olivotto IA. Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer. American Journal of Surgery. 191: 749-55. PMID 16720143 DOI: 10.1016/J.Amjsurg.2005.07.028  0.379
2006 Berthelet E, Truong PT, Lesperance M, Lim JT, Wai ES, MacNeil MV, Liu M, Joe H, Olivotto IA. Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer. American Journal of Clinical Oncology. 29: 21-6. PMID 16462498 DOI: 10.1097/01.Coc.0000195092.25516.19  0.331
2006 Truong PT, Liz K, Lesperance M, Chia S, Macfarlane R, Speers CH, Olivotto IA. 56 Micrometastatic node-positive breast cancer: An analysis of outcomes in comparison to node-negative and macrometastatic node-positive disease Radiotherapy and Oncology. 80. DOI: 10.1016/S0167-8140(06)80797-8  0.302
2005 Truong PT, Lesperance M, Culhaci A, Kader HA, Speers CH, Olivotto IA. Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy. International Journal of Radiation Oncology, Biology, Physics. 62: 175-82. PMID 15850919 DOI: 10.1016/J.Ijrobp.2004.09.013  0.362
2005 Truong PT, Kader HA, Lacy B, Lesperance M, MacNeil MV, Berthelet E, McMurtrie E, Alexander S. The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer. American Journal of Clinical Oncology. 28: 157-64. PMID 15803010 DOI: 10.1097/01.Coc.0000143049.05090.12  0.304
2004 Truong PT, Lesperance M, Culhaci A, Speers C, Olivotto IA. Are there patient subsets at high locoregional failure risks after mastectomy for pT1/2 pN0 breast cancer that may warrant radiotherapy International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.06.035  0.363
2003 Ludbrook JJ, Truong PT, MacNeil MV, Lesperance M, Webber A, Joe H, Martins H, Lim J. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis. International Journal of Radiation Oncology, Biology, Physics. 55: 1321-30. PMID 12654444 DOI: 10.1016/S0360-3016(02)04576-5  0.324
2003 Berthelet E, Truong PT, Lesperance M, Lim J, MacNeil M, Ludbrook J. P-64 The timeliness of diagnosis, staging and treatment in patients with limited stage small cell lung cancer (L-SCLC): A population-based analysis Lung Cancer. 41. DOI: 10.1016/S0169-5002(03)92033-2  0.315
1992 Lesperance ML, Kalbfleisch JD. An algorithm for computing the nonparametric MLE of a mixing distribution Journal of the American Statistical Association. 87: 120-126. DOI: 10.1080/01621459.1992.10475182  0.43
Show low-probability matches.